Confirming Abnormal Blood Test Results in Impaired Glucose Regulation
You must confirm any abnormal blood glucose test result with a second test performed without delay, using either the same test repeated or a different glucose test, unless the patient presents with unequivocal hyperglycemia (random glucose ≥200 mg/dL with classic symptoms). 1, 2
Diagnostic Confirmation Algorithm
Step 1: Determine if Confirmation is Needed
- Skip confirmation only if: Patient has classic hyperglycemia symptoms (polyuria, polydipsia, weight loss) AND random plasma glucose ≥200 mg/dL (11.1 mmol/L) 1
- Require confirmation for: All other abnormal results, including isolated elevated fasting glucose, HbA1c, or 2-hour OGTT values 1, 2
Step 2: Choose Your Confirmation Method
- Preferred approach: Repeat the same test that was initially abnormal, as this provides the greatest likelihood of concordance 2, 3
- Alternative approach: Use a different test (e.g., if initial HbA1c was elevated, confirm with fasting plasma glucose or OGTT) 1
- Both tests elevated: If two different tests from the same or separate samples are both above diagnostic thresholds, diagnosis is confirmed without further testing 1, 2
Step 3: Timing of Confirmatory Testing
- Perform without delay for most patients with clearly abnormal results 2, 3
- Wait 3-6 months only if results are near diagnostic margins (e.g., HbA1c 6.4-6.6%, fasting glucose 124-128 mg/dL) 1, 2
Diagnostic Thresholds Requiring Confirmation
For Diabetes Diagnosis:
- HbA1c ≥6.5% (48 mmol/mol) using NGSP-certified laboratory method 1
- Fasting plasma glucose ≥126 mg/dL (7.0 mmol/L) after ≥8 hours fasting 1
- 2-hour OGTT ≥200 mg/dL (11.1 mmol/L) using 75g glucose load 1
For Impaired Glucose Regulation:
- Impaired fasting glucose: Fasting glucose 100-125 mg/dL (ADA criteria) or 110-125 mg/dL (WHO criteria) 1, 3
- Impaired glucose tolerance: 2-hour OGTT 140-199 mg/dL with fasting <126 mg/dL 1, 3
Handling Discordant Results
If two different tests give conflicting results (one above, one below diagnostic threshold):
- Repeat the test that was above the diagnostic cutpoint 1, 2
- Make diagnosis based on the confirmed elevated test 1
- Example: If HbA1c is 7.0% and 6.8% on repeat, diabetes is confirmed even if fasting glucose is <126 mg/dL 1, 2
Critical Sample Handling Requirements
For plasma glucose measurements:
- Samples must be centrifuged and separated immediately after blood draw 1, 2
- Glucose samples left at room temperature without prompt separation will yield falsely low results due to ongoing glycolysis 1
- This preanalytic error is the most common cause of false-negative results 1, 2
When NOT to Use HbA1c for Diagnosis
Use only plasma glucose criteria in these conditions: 1
- Sickle cell disease or sickle cell trait (use interference-free assay if available) 1
- Pregnancy (second and third trimesters) 1
- Glucose-6-phosphate dehydrogenase deficiency 1
- Recent blood loss or transfusion 1
- Hemodialysis 1
- Erythropoietin therapy 1
- HIV on certain antiretroviral drugs 1
- Iron-deficiency anemia 1
Cardiovascular Risk Assessment in Confirmed Impaired Glucose Regulation
Once impaired glucose regulation is confirmed, immediately assess:
- Complete lipid panel (total cholesterol, LDL, HDL, triglycerides) 1, 3
- Blood pressure measurement 1, 3
- Microalbuminuria (albumin-to-creatinine ratio) 1
- Estimated glomerular filtration rate 1
- Electrocardiogram if hypertension present or CVD suspected 1
These patients have 2-fold increased risk of coronary heart disease and stroke compared to normal glucose metabolism 1
Follow-up Testing Schedule
- If initial test is normal: Rescreen every 3 years minimum 1
- If impaired glucose regulation confirmed: Consider HbA1c monitoring every 6 months to detect progression 3
- If results near diagnostic margins: Repeat in 3-6 months 1, 2
Common Pitfalls to Avoid
- Don't rely on fasting glucose alone in patients with cardiovascular disease—OGTT detects 2-3 times more cases of diabetes and impaired glucose tolerance 1, 4
- Don't perform OGTT within 4-5 days of acute coronary syndrome—wait to avoid false-positive results 1
- Don't use point-of-care HbA1c devices for diagnosis—only NGSP-certified laboratory methods are acceptable 1
- Don't ignore racial/ethnic differences—African Americans may have HbA1c levels 0.4% higher than non-Hispanic whites at similar glucose levels 1